BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/28/2026 9:12:05 AM | Browse: 7 | Download: 19
Publication Name World Journal of Hepatology
Manuscript ID 121019
DOI 10.4254/wjh.121019
Country Mexico
Category Gastroenterology & Hepatology
Manuscript Type Opinion Review
Article Title Rethinking metabolic risk in primary biliary cholangitis: The prognostic impact of lean type 2 diabetes mellitus
Manuscript Source Invited Manuscript
All Author List Fernanda M Martínez-Díaz, Elsie A Jiménez-Cuevas, Mariana Montoya-López, Mariana M Ramírez-Mejía and Nahum Méndez-Sánchez
Funding Agency and Grant Number
Corresponding Author Nahum Méndez-Sánchez, Liver Research Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, Col. Toriello Guerra, Mexico City 14050, Mexico. nmendez@medicasur.org.mx
Key Words Type 2 diabetes mellitus; Primary biliary cholangitis; Body mass index; Mortality; Metabolic dysfunction
Core Tip Primary biliary cholangitis presents marked clinical heterogeneity that is not fully explained by the current prognostic models. These models are primarily based on the biochemical response to ursodeoxycholic acid and the fibrosis stage. Emerging evidence suggests that metabolic dysfunction, particularly type 2 diabetes mellitus in lean individuals, is an underrecognized modifier of disease progression and mortality. Recent findings indicate synergistic adverse effects between the thin phenotype and diabetes, which challenges traditional body mass index-based assumptions regarding metabolic risk in patients with primary biliary cholangitis. Thus, beyond weight, comprehensive metabolic assessment should be incorporated into risk stratification strategies. In addition, future prospective studies should evaluate whether integrating lean type 2 diabetes mellitus into existing prognostic models can improve individualized patient management.
Citation Martínez-Díaz FM, Jiménez-Cuevas EA, Montoya-López M, Ramírez-Mejía MM, Méndez-Sánchez N. Rethinking metabolic risk in primary biliary cholangitis: The prognostic impact of lean type 2 diabetes mellitus. World J Hepatol 2026; In press
PDF 121019-in-press.pdf
Received
2026-03-13 02:51
Peer-Review Started
2026-03-13 02:52
First Decision by Editorial Office Director
2026-03-20 11:45
Return for Revision
2026-03-22 00:59
Revised
2026-07-16 00:30
Publication Fee Transferred
Second Decision by Editor
2026-08-28 02:55
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-08-28 09:12
Articles in Press
2026-08-28 09:12
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com